New Study Shows mRNA COVID-19 Vaccines Safe for Pregnant People: C-VIPER Pregnancy Registry Finds No Increased Risk of Spontaneous Abortion Waltham, MA, March 16, 2023 – CorEvitas, LLC (“CorEvitas”), a leading provider of syndicated registries, is pleased to share important safety information...Learn More
News
Jan 9 2023 - 7:00am
WALTHAM, MA — January 9, 2023 — CorEvitas, LLC, the leading sponsor of syndicated clinical registries in autoimmune and inflammatory diseases, has launched and is recruiting patients in a first-of-its-kind registry to evaluate the safety and effectiveness of newly approved therapies for patients...Learn More
News
Nov 21 2022 - 12:00pm
Investment augments CorEvitas’ pharmacovigilance services to fulfill global regulatory requirements for the safety of medications and vaccines during pregnancy Waltham, MA and Los Angeles, CA, November 22, 2022 – CorEvitas, LLC (“CorEvitas”), an industry leader in syndicated registries, announced...Learn More
News
Jul 6 2022 - 6:00am
Waltham, MA and London, UK, July 6, 2022 — CorEvitas, LLC is excited to announce expanded services to include specialty EMR data through its Specialty EMR Data Business Unit. Health iQ Limited, a subsidiary of CorEvitas, has provided innovative real-world evidence solutions in the United Kingdom...Learn More